Magazine Article | January 4, 2021

China's Proposed IP Law Changes May Drive Pharma Innovation

Source: Life Science Leader

By David Vondle

Despite the geopolitical environment and the high-technology industry obtaining much of the attention from governments and media in the U.S. and China, a fast-growing pharmaceutical and life sciences industry exists in China, particularly early-stage pharmaceutical companies seeking additional capital and partners for R&D.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: